{"tm":1686891593,"s":"RETA","news":[{"t":"Reata Pharmaceuticals Appoints Rajiv Patni, M.D., as Executive Vice President, Chief Research &amp; Development Officer","dt":"Jun-13-23 06:45AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/reata-pharmaceuticals-appoints-rajiv-patni-104500462.html"},{"t":"Reata Pharmaceuticals Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference","dt":"Jun-06-23 04:31PM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/reata-pharmaceuticals-announces-participation-goldman-203100564.html"},{"t":"Daily  Vickers Top Buyers &amp; Sellers for 05\/18\/2023","dt":"06:39AM","a":"Argus Research","u":"https:\/\/finance.yahoo.com\/m\/8abfc9c6-f1da-33f1-9bb5-8cd978524afc\/daily-%E2%80%93-vickers-top-buyers-%26.html"},{"t":"Top 1% Biotech Reata Crashes On A Delay For Its Most Anticipated Drug","dt":"May-10-23 04:04PM","a":"Investor's Business Daily","u":"https:\/\/finance.yahoo.com\/m\/a7f382ec-266c-3c6c-9dce-9e3413e7a577\/top-1%25-biotech-reata-crashes.html"},{"t":"Reata Pharmaceuticals, Inc. to Report First Quarter 2023 Financial Results and to Provide an Update on Operational Progress and Clinical Development Programs on May 10, 2023","dt":"May-02-23 05:45PM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/reata-pharmaceuticals-inc-report-first-214500375.html"},{"t":"Here's Why You Should Invest in Larimar (LRMR) Stock Now","dt":"Apr-12-23 12:07PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/heres-why-invest-larimar-lrmr-160704609.html"},{"t":"The 3 Best Growth Stocks to Buy in the Biotech Sector","dt":"Mar-29-23 10:23PM","a":"InvestorPlace","u":"https:\/\/finance.yahoo.com\/news\/3-best-growth-stocks-buy-022348447.html"},{"t":"US Government Assures Fund Accessibility to SVB (SIVB) Clients","dt":"10:21AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/us-government-assures-fund-accessibility-142102295.html"},{"t":"Reata Pharmaceuticals Announces Participation in the Barclays Global Healthcare Conference","dt":"06:40AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/reata-pharmaceuticals-announces-participation-barclays-114000463.html"},{"t":"Why Reata Pharmaceuticals Stock Skyrocketed This Week","dt":"Mar-02-23 01:42PM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/87dce8ac-0ee1-3a0c-b2c2-2fe58efb381d\/why-reata-pharmaceuticals.html"},{"t":"Reatas new rare-disease drug will cost $370,000 per year","dt":"02:53PM","a":"MarketWatch","u":"https:\/\/finance.yahoo.com\/m\/25583fea-87fa-3a57-8c4c-64962db59c88\/reata%E2%80%99s-new-rare-disease-drug.html"},{"t":"Investors Just Hit the Jackpot on These 2 Nasdaq Biotech Stocks","dt":"09:09AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/702e0f13-5831-3d06-b217-af9c5603ca37\/investors-just-hit-the.html"},{"t":"Reata Stock Soars on Approval for Rare Disorder Drug. Its Pipeline Impresses Analysts.","dt":"07:14AM","a":"Barrons.com","u":"https:\/\/finance.yahoo.com\/m\/7cc554f9-f79f-3419-9c3f-b115b54e5087\/reata-stock-soars-on-approval.html"},{"t":"Reatas stock soars 150% after FDA approves rare-disease drug amid uncertainty about approach to neuroscience treatments","dt":"Feb-28-23 08:14PM","a":"MarketWatch","u":"https:\/\/finance.yahoo.com\/m\/cca32b9f-3903-314f-b12a-bfecb212c358\/reata%E2%80%99s-stock-soars-150%25.html"},{"t":"Reatas stock nearly triples after FDA approves rare-disease drug amid uncertainty about approach to neuroscience treatments","dt":"06:31PM","a":"MarketWatch","u":"https:\/\/finance.yahoo.com\/m\/cca32b9f-3903-314f-b12a-bfecb212c358\/reata%E2%80%99s-stock-nearly-triples.html"},{"t":"Reata Pharmaceuticals Announces FDA Approval of SKYCLARYS (Omavaloxolone), the First and Only Drug Indicated for Patients with Friedreichs Ataxia","dt":"05:25PM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/reata-pharmaceuticals-announces-fda-approval-222500644.html"},{"t":"Why Reata Pharmaceuticals Shares Are Falling Monday?","dt":"02:39PM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/why-reata-pharmaceuticals-shares-falling-193943884.html"},{"t":"The Nasdaq Is Rebounding: 2 Supercharged Growth Stocks to Buy in February","dt":"Feb-01-23 10:30AM","a":"Motley Fool","u":"https:\/\/finance.yahoo.com\/m\/82bc4881-fa69-3360-853b-140ee0dba5ea\/the-nasdaq-is-rebounding%3A-2.html"},{"t":"Reata Pharmaceuticals (NASDAQ:RETA) shareholders have endured a 84% loss from investing in the stock three years ago","dt":"Dec-22-22 10:42AM","a":"Simply Wall St.","u":"https:\/\/finance.yahoo.com\/news\/reata-pharmaceuticals-nasdaq-reta-shareholders-154215885.html"},{"t":"Reata Pharmaceuticals Announces Participation in the Guggenheim 2022 Immunology and Neurology Conference and the Stifel 2022 Healthcare Conference","dt":"Nov-10-22 04:42PM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/reata-pharmaceuticals-announces-participation-guggenheim-214200131.html"},{"t":"Reata Pharmaceuticals, Inc. (RETA) Reports Q3 Loss, Lags Revenue Estimates","dt":"07:55AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/reata-pharmaceuticals-inc-reta-reports-125512687.html"},{"t":"2 On-Fire Biotech Stocks That Are Crushing the Bear Market","dt":"09:30AM","a":"Motley Fool","u":"https:\/\/www.fool.com\/investing\/2022\/10\/31\/2-on-fire-biotech-stocks-that-are-crushing-the-bea\/?source=eptyholnk0000202&utm_source=yahoo-host&utm_medium=feed&utm_campaign=article"},{"t":"Reata (RETA) Up After FDA Scraps AdCom Meeting for NDA Filing","dt":"Oct-17-22 12:52PM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/reata-reta-fda-scraps-adcom-165204776.html"},{"t":"Reata Pharma (RETA) is Striving Hard Despite Pipeline Setbacks","dt":"Oct-04-22 08:58AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/reata-pharma-reta-striving-hard-125812255.html"},{"t":"Reata Pharmaceuticals, Inc. (RETA) Up 4.7% Since Last Earnings Report: Can It Continue?","dt":"Sep-07-22 11:30AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/reata-pharmaceuticals-inc-reta-4-153003395.html"},{"t":"FDA Pushes Decision Date For Reata's Genetic Neuromuscular Disease Candidate","dt":"Aug-09-22 12:04PM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/fda-pushes-decision-date-reatas-160447309.html"},{"t":"Why Reata Pharma Shares Are Trading Lower After Q2 Earnings Update?","dt":"Aug-08-22 10:16AM","a":"Benzinga","u":"https:\/\/finance.yahoo.com\/news\/why-reata-pharma-shares-trading-141612453.html"},{"t":"Reata Pharmaceuticals, Inc. Announces Second Quarter 2022 Financial Results and Provides an Update on Clinical Development Programs","dt":"06:45AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/reata-pharmaceuticals-inc-announces-second-104500916.html"},{"t":"Reata Announces the Appointment of Steven W. Ryder, M.D. to its Board of Directors","dt":"Jul-11-22 06:45AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/reata-announces-appointment-steven-w-104500430.html"},{"t":"Reata (RETA) Up More Than 12% YTD: What's Driving the Rally?","dt":"May-31-22 10:11AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/reata-reta-more-12-ytd-141102946.html"},{"t":"Reata Pharmaceuticals Announces FDA Filing Acceptance and Priority Review Designation for the NDA for Omaveloxolone for the Treatment of Patients with Friedreichs Ataxia","dt":"06:45AM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/reata-pharmaceuticals-announces-fda-filing-104500865.html"},{"t":"Reata Pharmaceuticals, Inc. (RETA) Reports Q1 Loss, Misses Revenue Estimates","dt":"07:55AM","a":"Zacks","u":"https:\/\/finance.yahoo.com\/news\/reata-pharmaceuticals-inc-reta-reports-115511693.html"},{"t":"Reata Pharmaceuticals, Inc. to Report First Quarter 2022 Financial Results and to Provide an Update on Clinical Development Programs on May 10, 2022","dt":"May-02-22 04:31PM","a":"Business Wire","u":"https:\/\/finance.yahoo.com\/news\/reata-pharmaceuticals-inc-report-first-203100942.html"}]}